TYK2 and psoriasis: Further analyses on the function of DCs and CD4+ T cells revealed no significant alterations in PBMC and iLN (Figure S3C–G), suggesting that the topical application of TYK2 inhibitor did not significantly affect the global immunity of psoriasis mice.